Education
About Us
Working with TipRanks
Follow Us
Newton Charles W. Insider Profile
11 Followers
Newton Charles W., CFO at Lyell Immunopharma, holds 372.73K shares in Lyell Immunopharma (Ticker: LYEL), holds ― shares in Coherus Biosciences (Ticker: CHRS), holds 22.63K shares in 2seventy bio (Ticker: TSVT). Most recently, Newton Charles W. Bought ― shares of Lyell Immunopharma on Mar 18, 2025 for an estimated value of 110.00K.
Newton Charles W. has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
Compare to
Insider Holdings
Insider Roles
Roles that Newton Charles W. holds in companies
Most Profitable Insider Trade
The most profitable trade made by Newton Charles W.
Newton Charles W.'s Trading History
Lyell Immunopharma
Mar 18, 2025
CFO
Informative Buy
110.00K
$3.54M
Coherus Biosciences
―
Director
―
―
2seventy bio
Jun 12, 2024
―
Uninformative Buy
―
$113.13K
Novavax
―
Director
―
―
List of latest transactions for each holding click on a transaction to see Newton Charles W.'s performance on stock
You May Also Like
Newton Charles W. insider profile FAQ
What is the percentage of profitable transactions made by Newton Charles W.?
The percentage of profitable transactions made by Newton Charles W. is ―.
What is the average return per transaction made by Newton Charles W.?
The average return per transaction made by Newton Charles W. is ―.
What stocks does Newton Charles W. hold?
Newton Charles W. holds: LYEL, CHRS, TSVT, NVAX stocks.
What was Newton Charles W.’s latest transaction?
Newton Charles W. latest transaction was an Informative Buy of $110.00K.
What was Newton Charles W.'s most profitable transaction?
Newton Charles W.’s most profitable transaction was an Informative Buy of LYEL stock on March 18, 2025. The return on the trade was -4.40%.
What is Newton Charles W.'s role in Lyell Immunopharma?
Newton Charles W.'s role in Lyell Immunopharma is CFO.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.